Alnylam Pharmaceuticals
ALNY
#564
Rank
HK$332.52 B
Marketcap
HK$2,507
Share price
0.05%
Change (1 day)
30.01%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company